Pharmaceutical news and in-depth feature articles on the new drug discoveries, healthcare research and development, big pharma trends and company deals.

Pfizer’s colon cancer combo approval further supported by Phase III win. Pfizer’s metastatic colorectal cancer (mCRC) combination therapy has met one of the primary endpoints of improving progression-free survival (PFS) in…

2022年1月5日 · Pharma: the big picture. While artificial intelligence and robotics continue to gain popularity in the pharma lexicon, Darcy Jimenez took a closer look at more specific ways in which technology can influence drug development research.In a separate article, Manasi Vaidya discovers that, fueled by the successful use of mRNA vaccines in Covid-19, RNA therapeutics are expected to make larger ...

4 天之前 · The appetite for radiopharmaceuticals has been reflected in moves made by some of the largest pharmaceutical companies in recent months. In September 2024, Sanofi signed a $100 million licensing deal with Houston, Texas-based RadioMedix and Plano, Texas-based Orano Med to develop radiopharmaceuticals for neuroendocrine tumours, after Eli Lilly signed its own deal with Durham, North Carolina ...

2021年12月14日 · When we think of new technologies in medicine, we tend to conjure images of futuristic AI computers, 3D-printed organs, and robot surgeons.The ambitious and lesser-explored methods currently being applied in drug discovery and development, however, could prove to be just as exciting.. A GlobalData survey this year revealed that over 70% of pharma industry respondents anticipate drug ...

2025年1月27日 · According to a survey by GlobalData, the parent company of Pharmaceutical Technology, AI is considered the most disruptive technology among businesses, including in the healthcare industry.As we look towards 2025 and beyond, the question arises: how close are we to seeing AI’s potential in delivering faster, more affordable, and more precise therapies?

2025年1月23日 · The year ahead in clinical trials looks set to be one that is challenged and influenced by regulatory developments, new guidance, and broader political shifts. This month’s cover feature examines the biggest factors to keep an eye on as the year unfolds. Also in this issue, we explore the World ...

2023年12月19日 · As the year comes to a close, we at Pharmaceutical Technology take stock at some of the biggest headlines of the year. One of the most popular stories on the site was a forward-looking feature that outlined the biggest expected catalysts involving CRISPR gene therapies and posited 2023 as the milestone year for this approach. The interest in this cutting edge technology was unsurprising given ...

2023年12月20日 · Pharma breakthroughs: 10 novel drug approvals that made headlines in 2023 Pharmaceutical Technology outlines some of the biggest US Food and Drug Administration (FDA) drug approvals announced in 2023 that are set to make an impact in the coming years.

2024年11月27日 · Commenting on the results Urte Jakimaviciute, senior director of market research and strategic intelligence at GlobalData, said: “Survey findings highlight that the growing recognition within the pharmaceutical industry that technology, particularly AI, is accelerating innovation and efficiency in the drug discovery and development process, enabling processes such as faster identification of ...